Astrazenca Pharma India has reported total income of Rs.212.80 crores during the period ended March 31, 2021 as compared to Rs.203.18 crores during the period ended December 31, 2020. It reported total income of Rs.198.27 crores during the period ended March 31, 2020.

The company has posted net profit of Rs.27.27 crores for the period ended March 31, 2021 as against net profit of Rs.21.05 crores for the period ended December 31, 2020. The company posted net profit of Rs.9.57 crores for the period ended March 31, 2020.

Astrazenca Pharma India has reported total income of Rs.826.40 crores for FY 2020-21 as compared to Rs.844.79 crores during FY 2019-20.

The company has posted net profit of Rs.93.30 crores for FY 2020-21 as against net profit of Rs.72.22 crores for FY 2019-20. 

Astrazenca Pharma India has reported EPS of Rs.37.32 for the 12 months period ended March 31, 2021 as compared to Rs.28.89 for the 12 months period ended March 31, 2020.